Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000134325) titled 'Extended Insulin Infusion in People with Type 1 Diabetes Feasibility Trial' on Feb. 3.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Type of endpoint: Safety/efficacy
Primary Sponsor: Edge Trials Limited
Condition:
Type 1 diabetes
Type 1 diabetes
Metabolic and Endocrine - Diabetes
Intervention:
This is a single-arm interventional study with two cohorts.
Cohort 1: Up to 10 participants aged 6 years and older with type 1 diabetes will use the approved Insulet Omnipod 5 (OP5) Automated Insulin Delivery (AID) System with 3-day P...